Federated Hermes
CALA

Federated Hermes’s Calithera Biosciences, Inc CALA Stock Holding History

Federated Hermes’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-71
Closed -$1K – 2350
2022
Q1 		$1K Hold
71
– – ﹤0.01% 2161
2021
Q4 		$1K Sell
71
-333,378
-100% -$8.38M ﹤0.01% 2189
2021
Q3 		$14.5M Hold
333,449
– – 0.03% 556
2021
Q2 		$13.9M Buy
333,449
+59
+0% +$2.59K 0.03% 572
2021
Q1 		$16.1M Sell
333,390
-38,740
-10% -$2.25M 0.03% 548
2020
Q4 		$36.5M Sell
372,130
-521
-0.1% -$45.7K 0.07% 311
2020
Q3 		$25.7M Buy
372,651
+733
+0.2% +$64K 0.06% 360
2020
Q2 		$39.3M Buy
371,918
+25,188
+7% +$2.99M 0.1% 242
2020
Q1 		$30.8M Hold
346,730
– – 0.09% 244
2019
Q4 		$39.6M Buy
346,730
+14
+0% +$1.05K 0.09% 249
2019
Q3 		$21.4M Buy
346,716
+72,463
+26% +$5.8M 0.05% 347
2019
Q2 		$21.4M Buy
274,253
+85,865
+46% +$9.75M 0.05% 333
2019
Q1 		$25.4M Buy
188,388
+10,943
+6% +$1.15M 0.06% 293
2018
Q4 		$14.2M Buy
177,445
+82,957
+88% +$8.18M 0.04% 387
2018
Q3 		$9.92M Buy
94,488
+43
+0% +$4.09K 0.02% 571
2018
Q2 		$9.45M Buy
94,445
+23,335
+33% +$2.64M 0.03% 466
2018
Q1 		$8.96M Buy
+71,110
New +$11.1M 0.03% 460

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Federated Hermes's CALA Position: Q2 2022 in Review

Federated Hermes sold out of Calithera Biosciences, Inc (CALA) in Q2 2022, closing a stake of 71 shares — an estimated $1K sold.

Federated Hermes first reported a position in CALA in Q1 2018 and held it in 17 quarters. The position peaked at $39.6M in Q4 2019. 28 funds tracked by Wall St. Rank hold CALA as of Q2 2022.

  • Federated Hermes reported no remaining Calithera Biosciences, Inc position as of Q2 2022 after selling out during the quarter.
  • Federated Hermes sold 71 Calithera Biosciences, Inc shares in Q2 2022, an estimated $1K.
  • Federated Hermes first reported a position in Calithera Biosciences, Inc in Q1 2018 and held it in 17 quarters.
  • Federated Hermes's Calithera Biosciences, Inc position peaked at $39.6M in Q4 2019.
  • 28 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2022.

Based on Federated Hermes's 13F filing for Q2 2022, filed 15 Aug 2022.